November 13-14 2025
Lyon, France
November 13-14 2025
Lyon, France
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 100,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.
Booth N°13 | www.sanofi.fr
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
At RNAlead, our mission is to provide our partners with a proprietary RNA delivery solution that is unique, versatile, and proven. We support our clients throughout their innovation journey — from early-stage research to clinical applications — with a turnkey solution designed to meet the evolving gene delivery demands of modern gene and cell therapy.
We are continuously optimizing our platform to enable targeted delivery to specific cell types in vivo, expanding its therapeutic potential and real-world impact. With the unmatched versatility of our platform, we unlock a broad range of therapeutic applications with a bold ambition: to become the go-to technology for genetic delivery.
WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation.
With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside nearly
6,000 partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time.
Booth N°10 | https://www.wuxiapptec.com/
Evotec is a life science company that is pioneering the future of drug discovery and development. By integrating breakthrough science with AI-driven innovation and advanced technologies, we accelerate the journey from concept to cure — faster, smarter, and with greater precision.
Our expertise spans small molecules, biologics, cell therapies and associated modalities, supported by proprietary platforms such as Molecular Patient Databases, PanOmics and iPSC-based disease modeling.
With flexible partnering models tailored to our customers’ needs, we work with all Top 20 Pharma companies, over 800 biotechs, academic institutions, and healthcare stakeholders. Our offerings range from standalone services to fully integrated R&D programs and long-term strategic partnerships, combining scientific excellence with operational agility.
Booth N°11 | http://www.evotec.com/ | info@evotec.com
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. Our R&D focus is on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.
Ardena is a leading European CRO offering an integrated and fully flexible range of pharmaceutical services.
Our bioanalytical capabilities range from unregulated early drug development services to regulated preclinical and clinical phases (Phases I-IV). We can work with all types of drugs and biomarkers, from small molecules to proteins, including antibodies, antibody conjugates and oligonucleotides.
Ardena supports international customers in their preclinical and clinical drug development research with the production of their APIs and formulations (CDMO), as well as bioanalytical method development and services (CRO), for both PK and biomarkers.
Booth N°4 | https://www.ardena.com/
Depuis plus de 70 ans, Bio-Rad accompagne les acteurs des biotechnologies, de l’industrie pharmaceutique et du monde académique. Nous accélérons le développement des immunothérapies et autres thérapies innovantes avec des solutions fiables en qPCR, PCR digitale, Western blot, cytométrie, chromatographie et développement d’anticorps sur mesure. Nos technologies couvrent l’ensemble du workflow, de la recherche à la production, avec performance et reproductibilité. Discutons de vos projets.
Booth N°M5 | https://www.bio-rad.com/
Bruker Biosensors offers cutting-edge biophysical technologies to advance research, with a strong focus on enabling precise, in vivo-relevant insights. Our single-cell Interaction Cytometry stands out by allowing researchers to measure binding kinetics directly on living cells, preserving the native environment of target receptors within the cell membrane. Additionally, switchSENSE enables the characterization of intricate interactions such as ternary complexes, multispecific binders, and conformational changes. Our state-of-the-art SPR devices provide exceptional sensitivity and flexibility for applications ranging from high-throughput epitope binning to assay development. Together, these technologies deliver comprehensive solutions to meet the growing demands of modern drug discovery.
Booth N°M2 | https://www.bruker.com/spr | info.biosensors@bruker.com
ERBC is a leading preclinical CRO specializing in safety assessment—including safety pharmacology, genetic toxicology, in-vitro and in-silico toxicology, general toxicology, juvenile and reproductive & developmental toxicology—along with pharmacokinetics, bio-analytics, and translational research. Committed to scientific excellence and regulatory compliance, ERBC partners with pharmaceutical, biotech, chemical, and medical device companies to de-risk their development programs and advance human health.
Booth N°6 | / www.erbc-group.com I info@erbc-group.com
Greiner Bio-One has been developing and distributing high-quality plastic products for medical and lab use for over 60 years. Its solutions support diagnostics, life science research, drug discovery, and medical device sterilization. The BioScience Division partners with universities and biotech players, focusing on cell culture containers and microplates for high-throughput biochemical and pharmacological testing.
Booth N°M3 | https://www.gbo.com/fr-fr/ | Cyril.Domenjoz@gbo.com
At Integrated DNA Technologies, we are a leading provider of custom nucleic acid-based products for the life sciences industry. Our innovative solutions cater to a wide range of applications, including academic research, biotechnology, and clinical diagnostics. With a commitment to quality and customer satisfaction, we strive to empower scientists and researchers worldwide to achieve their goals in genomics and molecular biology.
Booth N°M6 | https://eu.idtdna.com/page | sgermany@idtdna.com | emea-custcare@idtdna.com
Kimialys unlocks new in vitro analysis possibilities for the detection and characterization of biomolecules. Leveraging its patented functionalization technology K-One applied to nanoparticles and chips, Kimialys enables drug discovery researchers and diagnostics developers across the globe achieve innovative assays for cutting-edge applications: SPR characterization of complex biologics, detection of biomarkers in low concentrations in complex matrices, innovative rapid tests, and so forth.
Booth N°8 | https://www.kimialys.com/ | cyril.gilbert@kimialys.com
Kymos is a CRO that provides high quality analytical services in small molecule and biologic fields.
Kymos has experience in the characterizacion of biological products according to ICH Q6D, what includes the determination of its physicochemical properties, biological activity, immunochemcial properties, purity, and impurities
Kymos works with three different platforms depending on the drug characteristics: ELISA, ECLA by Meso Scale Discovery (MSD®) and Radioimmunoassay. In addition, Kymos may provide label-free interaction studies using Surface Parma Resonance technology (Bicaore®)
Booth N°M1 | https://kymos.com/
PEPperPRINT is the leading provider of high-density peptide and protein microarrays for antibody characterization or the fingerprint analysis of antibody responses from biological samples. The product and service portfolio was recently complemented by T cell epitope mapping and monitoring, making PEPperPRINT a one-stop solution provider for the fingerprint analysis of immune responses, trusted by researchers around the world with over 250 peer-reviewed publications.
Booth N°7 | https://www.pepperprint.com/ | info@pepperprint.com
UNVEIL has developed an optical label-free instrument to easily characterize 20-300 nm nanoparticles (inc. all viral vectors, lipid nanoparticles, extracellular vesicles, etc.) in solution. Applications notably include empty-full capsid ratio, concentration and aggregation.
Booth N°16 | https://unveil-instruments.com/ | contact@unveil-instruments.com